Emma Yates

Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring

Richard Adams, Janet Graham, Philip Quirke et al. · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · 2021 · 49 citations

Medicine, Oncology, Pharmacotherapy +17

Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer

Louise Brown, Janet Graham, David J. Fisher et al. · Clinical Trials · 2022 · 26 citations · Full text

Medicine, Biostatistics, Oncology +17

Prognostic factors for survival in patients with amyotrophic lateral sclerosis: analysis of a multi-centre clinical trial

Emma Yates, Muhammad K Rafiq · Journal of Clinical Neuroscience · 2016 · 15 citations

Life Sciences, Neurology, Neuroscience +13

Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial

Richard Adams, Janet Graham, Michel Seymour et al. · UCL Discovery (University College London) · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacology +14

FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing

Susan D. Richman, Gemma Hemmings, Helen Roberts et al. · Journal of Clinical Pathology · 2022 · 10 citations · Full text

Medicine, Oncology, Pathology +16